{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:45:01Z","timestamp":1794217501931,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The burden of undiagnosed obstructive lung disease (OLD) (mainly asthma and chronic obstructive pulmonary disease) is not fully established, and targets for corrective action are yet to be identified. We assessed the underdiagnosis of OLD and its determinants in France.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CONSTANCES is a French population-based cohort of adults aged 18\u201369\u00a0years at inception. We analysed data collected at inclusion in 2013\u20132014. Undiagnosed OLD was defined as spirometry-confirmed airflow limitation (FEV<jats:sub>1<\/jats:sub>\/FVC\u2009&lt;\u2009lower limit of normal) without prior diagnosis of asthma, chronic obstructive pulmonary disease, or bronchiectasis. Multivariate analysis was performed with weighted robust Poisson regression models to estimate the adjusted prevalence ratios (aPR) of undiagnosed OLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Spirometry results were available for 19,398 participants. The prevalence of airflow limitation was 4.6%. Overall, 64.4% of adults with airflow limitation did not report a previous diagnosis of OLD. Individuals with high cumulative tobacco consumption (\u2265\u200910 pack-years) (aPR: 1.72 [1.28\u20132.32]), without respiratory symptoms (aPR: 1.51 [1.28\u20131.78]), and with preserved lung function (aPR: 1.21 [1.04\u20131.41] for a 10-point increase in FEV<jats:sub>1<\/jats:sub>% predicted) had a higher risk of being undiagnosed. Half of symptomatic individuals with airflow limitation (45% of those with moderate to severe airflow limitation) were undiagnosed with OLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Underdiagnosis of OLD is very common among French adults, even in patients with respiratory symptoms. Efforts should be made in France to raise awareness about OLD in the general population, improve the detection of respiratory symptoms, and increase the use of spirometry among primary care professionals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-021-01688-z","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T14:26:29Z","timestamp":1634221589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Underdiagnosis of obstructive lung disease: findings from the French CONSTANCES cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Marie-Christine","family":"Delmas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"B\u00e9n\u00e9zet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Ribet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Iwatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Nadif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Leynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"1688_CR1","unstructured":"GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585\u201396. 2020."},{"issue":"8","key":"1688_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1164\/rccm.201804-0682CI","volume":"198","author":"SD Aaron","year":"2018","unstructured":"Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1688_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1378\/chest.14-2535","volume":"148","author":"B Lamprecht","year":"2015","unstructured":"Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971\u201385.","journal-title":"Chest"},{"issue":"8","key":"1688_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.rmr.2021.05.007","volume":"38","author":"MC Delmas","year":"2021","unstructured":"Delmas MC, B\u00e9n\u00e9zet L, Ribet C, Iwatsubo Y, Provost D, Varraso R, Zins M, Leynaert B, Nadif R, Roche N. Prevalence of asthma among adults in France, data from the Constances cohort study. Rev Mal Respir. 2021;38(8):797\u2013806.","journal-title":"Rev Mal Respir"},{"issue":"6","key":"1688_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1183\/09031936.00089607","volume":"31","author":"N Roche","year":"2008","unstructured":"Roche N, Dalmay F, Perez T, Kuntz C, Vergnenegre A, Neukirch F, et al. Impact of chronic airflow obstruction in a working population. Eur Respir J. 2008;31(6):1227\u201333.","journal-title":"Eur Respir J"},{"issue":"12","key":"1688_CR6","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.rmed.2015.10.012","volume":"109","author":"A Quach","year":"2015","unstructured":"Quach A, Giovannelli J, Cherot-Kornobis N, Ciuchete A, Clement G, Matran R, et al. Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: The ELISABET study 2011\u20132013. Respir Med. 2015;109(12):1553\u201361.","journal-title":"Respir Med"},{"issue":"12","key":"1688_CR7","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.rmed.2008.07.009","volume":"102","author":"M Akazawa","year":"2008","unstructured":"Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med. 2008;102(12):1744\u201352.","journal-title":"Respir Med"},{"issue":"7132","key":"1688_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/bmj.316.7132.651","volume":"316","author":"HC Siersted","year":"1998","unstructured":"Siersted HC, Boldsen J, Hansen HS, Mostgaard G, Hyldebrandt N. Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study. BMJ. 1998;316(7132):651\u20135.","journal-title":"BMJ."},{"key":"1688_CR9","doi-asserted-by":"crossref","unstructured":"Labont\u00e9 LE, Tan WC, Li PZ, Mancino P, Aaron SD, Benedetti A, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD Study. Am J Respir Crit Care Med. 2016;194(3):285\u201398.","DOI":"10.1164\/rccm.201509-1795OC"},{"key":"1688_CR10","doi-asserted-by":"crossref","unstructured":"Zins M, Goldberg M, team C. The French CONSTANCES population-based cohort: design, inclusion and follow-up. Eur J Epidemiol. 2015;30(12):1317\u201328.","DOI":"10.1007\/s10654-015-0096-4"},{"issue":"5","key":"1688_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1183\/09031936.94.07050954","volume":"7","author":"PG Burney","year":"1994","unstructured":"Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J. 1994;7(5):954\u201360.","journal-title":"Eur Respir J"},{"key":"1688_CR12","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2020 report. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: https:\/\/goldcopd.org."},{"issue":"1","key":"1688_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/s12889-016-3439-5","volume":"16","author":"F Ruiz","year":"2016","unstructured":"Ruiz F, Goldberg M, Lemonnier S, Ozguler A, Boos E, Brigand A, et al. High quality standards for a large-scale prospective population-based observational cohort: Constances. BMC Public Health. 2016;16(1):877.","journal-title":"BMC Public Health"},{"issue":"2","key":"1688_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"6","key":"1688_CR15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"key":"1688_CR16","unstructured":"UNESCO Institute for Statistics. International Standard Classification of Education: ISCED 2011. Available from: http:\/\/uis.unesco.org\/sites\/default\/files\/documents\/international-standard-classification-of-education-isced-2011-en.pdf."},{"issue":"6","key":"1688_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jclinepi.2013.10.017","volume":"67","author":"G Santin","year":"2014","unstructured":"Santin G, Geoffroy B, Benezet L, Delezire P, Chatelot J, Sitta R, et al. In an occupational health surveillance study, auxiliary data from administrative health and occupational databases effectively corrected for nonresponse. J Clin Epidemiol. 2014;67(6):722\u201330.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"1688_CR18","first-page":"129","volume":"25","author":"L Kish","year":"1999","unstructured":"Kish L. Cumulating\/combining population surveys. Surv Methodol. 1999;25(2):129\u201338.","journal-title":"Surv Methodol"},{"key":"1688_CR19","doi-asserted-by":"crossref","unstructured":"Martinez CH, Mannino DM, Jaimes FA, Curtis JL, Han MK, Hansel NN, et al. Undiagnosed obstructive lung disease in the United States. Associated Factors and Long-term Mortality. Ann Am Thorac Soc. 2015;12(12):1788\u201395.","DOI":"10.1513\/AnnalsATS.201506-388OC"},{"issue":"7","key":"1688_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/thorax.55.7.562","volume":"55","author":"CP van Schayck","year":"2000","unstructured":"van Schayck CP, van Der Heijden FM, van Den Boom G, Tirimanna PR, van Herwaarden CL. Underdiagnosis of asthma: Is the doctor or the patient to blame? The DIMCA project Thorax. 2000;55(7):562\u20135.","journal-title":"The DIMCA project Thorax"},{"key":"1688_CR21","first-page":"703","volume":"35\u201336","author":"MC Delmas","year":"2018","unstructured":"Delmas MC, Pasquereau A, Roche N, Andler R, Richard JB. Richard JB [Awareness of chronic obstructive pulmonary disease (COPD) in France: 2017 Health Barometer]. Bull Epidemiol Hebd. 2018;35\u201336:703\u20138.","journal-title":"Bull Epidemiol Hebd"},{"issue":"2","key":"1688_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2169\/internalmedicine.54.2916","volume":"54","author":"M Asai","year":"2015","unstructured":"Asai M, Tanaka T, Kozu R, Kitagawa C, Tabusadani M, Senjyu H. Effect of a chronic obstructive pulmonary disease (COPD) intervention on COPD awareness in a regional city in Japan. Intern Med. 2015;54(2):163\u20139.","journal-title":"Intern Med"},{"issue":"9","key":"1688_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.arbres.2012.04.008","volume":"48","author":"JB Soriano","year":"2012","unstructured":"Soriano JB, Calle M, Montemayor T, Alvarez-Sala JL, Ruiz-Manzano J, Miravitlles M. The general public\u2019s knowledge of chronic obstructive pulmonary disease and its determinants: current situation and recent changes. Arch Bronconeumol. 2012;48(9):308\u201315.","journal-title":"Arch Bronconeumol"},{"key":"1688_CR24","doi-asserted-by":"crossref","unstructured":"Walker SL, Saltman DL, Colucci R, Martin L, Canadian Lung Association Advisory C. Awareness of risk factors among persons at risk for lung cancer, chronic obstructive pulmonary disease and sleep apnea: a Canadian population-based study. Can Respir J. 2010;17(6):287\u201394.","DOI":"10.1155\/2010\/426563"},{"key":"1688_CR25","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Guide du parcours de soins: Bronchopneumopathie chronique obstructive. Saint-Denis: HAS, 2014. 63 p. Available from: https:\/\/www.has-sante.fr\/jcms\/c_1242507\/fr\/guide-du-parcours-de-soins-bronchopneumopathie-chronique-obstructive-bpco."},{"issue":"1","key":"1688_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12931-018-0731-1","volume":"19","author":"KM Johnson","year":"2018","unstructured":"Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M. Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2018;19(1):26.","journal-title":"Respir Res"},{"issue":"12","key":"1688_CR27","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.rmed.2005.03.032","volume":"99","author":"MC Zoia","year":"2005","unstructured":"Zoia MC, Corsico AG, Beccaria M, Guarnone R, Cervio G, Testi R, et al. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med. 2005;99(12):1568\u201375.","journal-title":"Respir Med"},{"issue":"2","key":"1688_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1479972310364587","volume":"7","author":"AJ Bastin","year":"2010","unstructured":"Bastin AJ, Starling L, Ahmed R, Dinham A, Hill N, Stern M, et al. High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at first hospital admission with acute exacerbation. Chron Respir Dis. 2010;7(2):91\u20137.","journal-title":"Chron Respir Dis"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2466-15-4","volume":"15","author":"E Balcells","year":"2015","unstructured":"Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodriguez E, Benet M, et al. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation. BMC Pulm Med. 2015;15:4.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"1688_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/resp.13648","volume":"25","author":"L Bhatta","year":"2020","unstructured":"Bhatta L, Leivseth L, Carslake D, Langhammer A, Mai XM, Chen Y, et al. Comparison of pre- and post-bronchodilator lung function as predictors of mortality: the HUNT Study. Respirology. 2020;25(4):401\u20139.","journal-title":"Respirology"},{"issue":"10","key":"1688_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/thx.2009.115725","volume":"64","author":"M Miravitlles","year":"2009","unstructured":"Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863\u20138.","journal-title":"Thorax"},{"issue":"5","key":"1688_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-2600(17)30119-4","volume":"5","author":"Y \u00c7olak","year":"2017","unstructured":"\u00c7olak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med. 2017;5(5):426\u201334.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"1688_CR33","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1164\/rccm.201911-2207OC","volume":"201","author":"DA Lipson","year":"2020","unstructured":"Lipson DA, Crim C, Criner GJ, Day NC, Dransfield MT, Halpin DMG, et al. Reduction in all-cause mortality with fluticasone furoate\/umeclidinium\/vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020;201(12):1508\u201316.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1688_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1916046","volume":"383","author":"KF Rabe","year":"2020","unstructured":"Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35\u201348.","journal-title":"N Engl J Med"},{"key":"1688_CR35","unstructured":"Global Intiative for Asthma. Global strategy for Asthma Management and Prevention, 2020. Available from: https:\/\/ginasthma.org\/."},{"key":"1688_CR36","unstructured":"Delmas MC, Guignon N, Leynaert B, Com-Ruelle L, Annesi-Maesano I, Chardon O, et al. [Trends in asthma prevalence in children in France: data from the national health surveys among schoolchildren, 2003\u20132008]. Bull Epidemiol Hebd. 2014;20:360\u20135."},{"issue":"5","key":"1688_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.rmr.2016.09.002","volume":"34","author":"MC Delmas","year":"2016","unstructured":"Delmas MC, Guignon N, Leynaert B, Moisy M, Marguet C, Fuhrman C. Increase in asthma prevalence among young children in France. Rev Mal Respir. 2016;34(5):525\u201334.","journal-title":"Rev Mal Respir"},{"key":"1688_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/eurpub\/ckz171","volume":"30","author":"V Olie","year":"2020","unstructured":"Olie V, Pasquereau A, Assogba FAG, Arwidson P, Nguyen-Thanh V, Chatignoux E, et al. Changes in tobacco-related morbidity and mortality in French women: worrying trends. Eur J Public Health. 2020;30:380\u20135.","journal-title":"Eur J Public Health"},{"issue":"1","key":"1688_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12931-018-0827-7","volume":"19","author":"PR Burgel","year":"2018","unstructured":"Burgel PR, Laurendeau C, Raherison C, Fuhrman C, Roche N. An attempt at modeling COPD epidemiological trends in France. Respir Res. 2018;19(1):130.","journal-title":"Respir Res"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01688-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T14:27:47Z","timestamp":1634221667000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01688-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01688-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the national and institutional committees on human experimentation and with the Helsinki Declaration, as revised in 2008. All procedures were approved by the Institutional Review Board of the French Institute of Health Research (INSERM). The CONSTANCES cohort was also approved by the French Data Protection Agency (CNIL). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NR reports grants or contracts from Boehringer Ingelheim, Novartis and Pfizer, consulting fees from GSK, AstraZeneca and Novartis, and Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Boehringer Ingelheim, Novartis, GSK, AstraZeneca, Chiesi, Sanofi and Zambon. All other authors have nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}